Get started
Author

Leanne Gough

OpenAlex ID: A5093778455
Comprehensive and Accurate Molecular Profiling of Breast Cancer through mRNA Expression of ESR1, PGR, ERBB2, MKI67, and a Novel Proliferation Signature
2024 · Anne-Sophie Wegscheider, Joanna Gorniak, et al. · Diagnostics · 8
PDF
Lessons learned from a hospital‐wide review of blood stream infections for paediatric central line‐associated blood stream infection prevention
2018 · Anita J Campbell, Christopher C Blyth, et al. · Journal of Paediatrics and Child Health · 7
Evaluating an RNA-based test for proliferation assessment and recurrence prediction in early HR+/HER2− breast cancer
2026 · Marcus Vetter, Elena Diana Chiru, et al. · Pathology & Oncology Research · 1
PDF
Enhancing HER2 evaluation: Correlation of APIS Breast Cancer Subtyping Kit and IHC/ISH with accurate HER2 quantification.
2024 · Anna Gasior, Anne-Sophie Wegscheider, et al. · Journal of Clinical Oncology · 1
Abstract P5-01-09: Improving ESR1 Mutations Detection in Breast Cancer Circulating Tumor DNA: Comparative Analysis of Enrichment Techniques
2025 · Anna Gasior, Joanna Gorniak, et al. · Clinical Cancer Research
Abstract P4-10-15: Evaluating the APIS ESR1 Mutations Kit: Performance and LoD Testing in Varied Wildtype Backgrounds
2025 · Anna Gasior, Joanna Gorniak, et al. · Clinical Cancer Research
Abstract P5-08-29: Assessment of RNA Extraction Protocols from FFPE Breast Cancer Samples with the APIS Breast Cancer Subtyping Kit
2025 · Anna Gasior, Joanna Gorniak, et al. · Clinical Cancer Research
Abstract P4-11-30: Assessing the APIS Breast Cancer Subtyping Kit for RNA-Based Risk Stratification in Older Patients: Swiss Cohort Findings
2025 · Anna Gasior, Marcus Vetter, et al. · Clinical Cancer Research
Abstract P5-12-22: Semi-Quantitative Stratification of Breast Cancer Biomarkers using the APIS Breast Cancer Subtyping Kit
2025 · Anna Gasior, Joanna Gorniak, et al. · Clinical Cancer Research
Abstract P4-11-13: High Progesterone Receptor (PR/PGR) Expression Determined by APIS Breast Cancer Subtyping Kit Correlates with Oncotype Dx Recurrence Score
2025 · Anna Gasior, Marcus Vetter, et al. · Clinical Cancer Research
1683 Design and Development of the APIS MET Alterations Kit to Detect MET Exon 14 Skipping Mutation (METΔex14) and MET Gene Overexpression Relevant to Acquired Therapy Resistance
2025 · Anna Gasior, Ryan Nana, et al. · Laboratory Investigation
Employing semi-quantitative methods to classify breast cancer markers (ER, PR, HER2, Ki67) expression, using the RT-qPCR based APIS Breast Cancer Subtyping Kit.
2024 · Anna Gasior, Anne-Sophie Wegscheider, et al. · Journal of Clinical Oncology
PDF
Abstract PO3-01-05: Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification
2024 · Anna Gasior, Joanna Gorniak, et al. · Cancer Research
Abstract PO1-02-08: Comprehensive Molecular Profiling of Breast Cancer: A real-time PCR assay for identifying ESR1, PGR, ERBB2, MKI67 and a novel proliferative signature in core needle biopsies and resected invasive breast cancer tissues
2024 · Anna Gasior, Joanna Gorniak, et al. · Cancer Research
Abstract PO4-03-01: Enhancing Breast Cancer Subtyping: APIS Breast Cancer Subtyping Kit Proliferative Signature's Potential for Improved Proliferation Assessment and Recurrence Prediction
2024 · Marcus Vetter, Anna Gasior, et al. · Cancer Research
Works count: 15
Citation count: 17
H-index: 2
I10-index:
Year
Topic
Type